OME Omega Protein Corporation

DEADLINE ALERT: Brower Piven Reminds Investors of the Upcoming Deadline in Class Action Lawsuit and Encourages Investors with Losses in Excess of $100,000 from Investment in Omega Protein Corporation to Contact the Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Omega Protein Corporation (NYSE: OME) (“Omega” or the “Company”) securities during the period between June 4, 2013 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 1, 2017 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Omega securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Omega’s subsidiary was potentially not in compliance with its probation terms, that the Company was not properly protecting whistleblower employees, and the Company was vulnerable to a U.S. Securities and Exchange Commission (“SEC”) investigation and potential civil and criminal liability.

According to the complaint, following a March 1, 2017 announcement that in December 2016 the Company received a subpoena from the SEC requesting information in connection with an investigation relating to the Company’s subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees, the value of Omega shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Omega securities purchased on or after June 4, 2013 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

EN
26/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Omega Protein Corporation

A director sold 13,738 shares at 22.000USD and

A director at Omega Protein Corp sold 13,738 shares at 22.000USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Omega Protein Corporation (NYSE: OME) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cooke Inc. Under the terms of the deal, Omega Protein shareholders will receive $22.00 for each share of Omega Protein stock they own. The investigation concerns whether the Omega Protein Board of Directors breached their fiduciary duties to Omega Protein stockholders ...

 PRESS RELEASE

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Omega Protein Corporation (“Omega Protein” or the “Company”) (NYSE:OME) stock prior to October 6, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Omega Protein to Cooke Inc. for $22.00 per share. To learn more about the action and your rights, go to: http://www.zlkdocs.com/OME-Info-Request-Form-m...

 PRESS RELEASE

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Omega Protein Corporation (“Omega Protein” or the “Company”) (NYSE: OME) stock prior to October 6, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Omega Protein to Cooke Inc. for $22.00 per share. To learn more about the action and your rights, go to: http://www.zlkdocs.com/OME-Info-Request-Form-...

 PRESS RELEASE

OMEGA PROTEIN CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willi...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Omega Protein Corporation (“Omega Protein”) (NYSE: OME) concerning the acquisition by Cooke Inc. Under the terms of the agreement, valued at approximately $500 million, Omega Protein shareholders will only receive $22.00 per Omega Protein share owned. The consideration is significantly lower than at least one analyst’s estimated value of $26.00. If...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch